Who owns GRI Bio Inc?
- Ticker: GRI
- CUSIP Number: 3622aw502
Tip: Access positions for across all investors
Analyze quarterly positions in GRI Bio with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of GRI Bio stock
Who bought or sold GRI Bio Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Hrt Financial | 29k | $50k | 100% | Jun 2026 |
|
| Vanguard Capital Management | 21k | $38k | 100% | Jun 2026 |
|
| Geode Capital Management | 14k | $25k | -25% | Jun 2026 |
|
| Citadel Advisors | 13k | $24k | 100% | Jun 2026 |
|
| UBS Group | 4.9k | $8.7k | -44% | Jun 2026 |
|
| Tower Research Capital | 2.4k | $4.3k | 130% | Jun 2026 |
|
| Barclays | 83.00 | $147.001300 | 100% | Jun 2026 |
|
| BlackRock | 7.00 | $12.000100 | 0% | Jun 2026 |
|
| Caitong International Asset Management | 2.00 | $4.000000 | 100% | Jun 2026 |
|
| Danske Bank A/s | 2.00 | $4.000000 | 0% | Jun 2026 |
|
Who sold out of GRI Bio?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| SBI Securities | Mar 2026 | 4.00 | $9.000000 |